Max Healthcare to participate in Motilal Oswal investor conference on Aug 18

0 min read     Updated on 12 Aug 2026, 11:43 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Max Healthcare Institute Ltd confirmed its attendance at the Motilal Oswal 22nd Annual Global Investor Conference on August 18, 2026. Representatives will conduct physical one-on-one and group meetings at the Grand Hyatt in Mumbai. The disclosure adheres to SEBI LODR Regulation 30, with no unpublished price-sensitive information expected to be shared.

powered bylight_fuzz_icon
48103970

*this image is generated using AI for illustrative purposes only.

Max Healthcare Institute Ltd will participate in the Motilal Oswal 22nd Annual Global Investor Conference on August 18, 2026. The healthcare provider disclosed that its representatives will hold physical meetings, including both one-on-one and group sessions, at the Grand Hyatt in Mumbai.

The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that no unpublished price-sensitive information is proposed to be shared during the event.

Meeting Details

Date Event Mode Type Location
August 18, 2026 Motilal Oswal 22nd Annual Global Investor Conference Physical One-on-one & Group Grand Hyatt, Mumbai

Dhiraj Aroraa, EVP - Company Secretary and Compliance Officer at Max Healthcare Institute Ltd, signed the disclosure dated August 12, 2026. The schedule is subject to change due to exigencies on the part of the investor or the company.

Historical Stock Returns for Max Healthcare Institute

1 Day5 Days1 Month6 Months1 Year5 Years
-3.13%-6.45%-8.92%-4.52%-20.25%+235.16%

What specific strategic initiatives or financial guidance is Max Healthcare likely to highlight to investors during the August 2026 conference?

How might the outcomes of these investor meetings influence Max Healthcare's stock valuation in the immediate weeks following the event?

Are there any pending regulatory approvals or expansion projects that Max Healthcare may use this platform to provide updates on?

Max Healthcare Institute
View Company Insights
View All News
like19
dislike

Max Healthcare Institute Sees ₹15.19 Crore Block Trade on NSE at ₹1,067.30 Per Share

0 min read     Updated on 10 Aug 2026, 09:54 AM
scanx
Reviewed by
Ritika DScanX News Team
AI Summary

Max Healthcare Institute recorded a block trade on the NSE involving approximately 1,42,335 shares at a price of ₹1,067.30 per share. The total value of the transaction stood at ₹15.19 crores. Block trades of this scale are generally associated with institutional or bulk investor activity and are closely tracked by market participants.

powered bylight_fuzz_icon
47881439

*this image is generated using AI for illustrative purposes only.

Max Healthcare Institute recorded a notable block trade on the National Stock Exchange (NSE), with approximately 1,42,335 shares changing hands in a single transaction. The trade was executed at a price of ₹1,067.30 per share, aggregating to a total deal value of ₹15.19 crores.

Block Trade Details

The following table summarises the key parameters of the block trade:

Parameter: Details
Exchange: NSE
Number of Shares: ~1,42,335
Trade Price: ₹1,067.30 per share
Total Trade Value: ₹15.19 crores

Significance of Block Trades

Block trades of this nature are typically executed by institutional investors or large stakeholders and are carried out as a single, sizeable transaction on the exchange. Such trades are closely monitored by market participants as they can reflect significant portfolio activity by major investors in the company.

Historical Stock Returns for Max Healthcare Institute

1 Day5 Days1 Month6 Months1 Year5 Years
-3.13%-6.45%-8.92%-4.52%-20.25%+235.16%

Who was the buyer and seller in this block trade, and does the transaction indicate a shift in institutional sentiment towards Max Healthcare?

How might this large-scale transaction impact Max Healthcare's short-term stock price volatility and trading volume on the NSE?

Does the execution price of ₹1,067.30 suggest a discount or premium relative to recent market averages, and what does this imply about investor valuation?

Max Healthcare Institute
View Company Insights
View All News
like15
dislike

More News on Max Healthcare Institute

1 Year Returns:-20.25%